Guidance on evaluation fees for human drugs and disinfectants: Invoicing, fee payment and mitigation measures

Guidance on evaluation fees for human drugs and disinfectants: Invoicing, fee payment and mitigation measures Sponsors must complete the fee section of the Regulatory Enrolment Process (REP) Regulatory Transaction (RT) template. The RT template provides a link to the fees, and includes a section on fee mitigation measures. 2023-09-01 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetydrug submissions-and-applicationshuman-drugs-and-disinfectants submissionguidance-document on feesfees for reviewevaluation feesinvoicingfee paymentmitigation measures Guidance on evaluation fees for human drugs and disinfectants: Invoicing, fee payment and mitigation measuresHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/fees-review-drug-submissions-applications/invoicing-payment-mitigation.html Guidance on evaluation fees for human drugs and disinfectants: Invoicing, fee payment and mitigation measuresHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/frais/examen-presentations-demandes-drogue/facturation-paiement-attenuation.html

Sponsors must complete the fee section of the Regulatory Enrolment Process (REP) Regulatory Transaction (RT) template. The RT template provides a link to the fees, and includes a section on fee mitigation measures.

Data and Resources

Similar records